LYRA THERAPEUTICS INC

CUSIP: 55234L105 Class: Common Stock

Ensign Peak Advisors, Inc's Holding History (CIK: 0001454984)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 591,311 Value ($000) $3,678 Avg Close — Range —
Q4 2023
Shares 301,533 Value ($000) $1,580 Avg Close — Range —
Q3 2023
Shares 301,533 Value ($000) $1,179 Avg Close — Range —
Q2 2023
Shares 302,235 Value ($000) $1,242 Avg Close — Range —
Q1 2023
Shares 302,235 Value ($000) $626 Avg Close — Range —
Q4 2022
Shares 302,235 Value ($000) $949 Avg Close — Range —
Q3 2022
Shares 63,210 Value ($000) $317 Avg Close — Range —
Q2 2022
Shares 56,229 Value ($000) $318 Avg Close — Range —
Q1 2022
Shares 39,167 Value ($000) $157 Avg Close — Range —
Q4 2021
Shares 39,167 Value ($000) $171 Avg Close — Range —
Q3 2021
Shares 39,167 Value ($000) $358 Avg Close — Range —
Q2 2021
Shares 39,167 Value ($000) $314 Avg Close — Range —
Q1 2021
Shares 39,167 Value ($000) $454 Avg Close — Range —
Q4 2020
Shares 39,167 Value ($000) $447 Avg Close — Range —
Q3 2020
Shares 39,167 Value ($000) $438 Avg Close — Range —
Q2 2020
Shares 15,000 Value ($000) $170 Avg Close — Range —